HCAR3 (hydroxycarboxylic acid receptor 3)
| Gene | |
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
8843 |
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Hydroxycarboxylic acid receptor 3 |
|
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
HCAR3 |
|
Synonyms (NCBI Gene)
Gene synonyms aliases
|
GPR109B, HCA3, HM74, PUMAG, Puma-g |
|
Chromosome
Chromosome number
|
12 |
|
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
12q24.31 |
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
|||||||
| Protein | |||||||||||
| UniProt ID | P49019 | ||||||||||
| Protein name | Hydroxycarboxylic acid receptor 3 (G-protein coupled receptor 109B) (G-protein coupled receptor HM74) (G-protein coupled receptor HM74B) (Niacin receptor 2) (Nicotinic acid receptor 2) | ||||||||||
| Protein function | Receptor for 3-OH-octanoid acid mediates a negative feedback regulation of adipocyte lipolysis to counteract prolipolytic influences under conditions of physiological or pathological increases in beta-oxidation rates. Acts as a low affinity rece | ||||||||||
| PDB | 8IHJ , 8IHK , 8JEF , 8JEI | ||||||||||
| Family and domains |
Pfam
|
||||||||||
| Tissue specificity | TISSUE SPECIFICITY: Expression largely restricted to adipose tissue and spleen. {ECO:0000269|PubMed:12522134}. | ||||||||||
| Sequence |
|
||||||||||
| Sequence length | 387 | ||||||||||
| Interactions | View interactions | ||||||||||
|
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|||||||||
|
|||||||||
|
Associated diseases
Disease associations categorized as Causal (pathogenic variants), Unknown (uncertain genetic evidence), or Text Mining (literature-based associations)
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||